Many people are being met with surprise bills from coronavirus treatment that cost thousands or tens of thousands of dollars, as patients battle with their insurers. More
One telemedicine vendor, which is giving away its technology for two months during the pandemic, discusses the value of virtual care during physical distancing. More
The inability of the healthcare system to manage the surge in response to COVID-19 wasn't just predictable. It was all but planned by economic design. More
States are releasing "Crisis Standards of Care" guidelines, aimed at helping desperate hospitals discern how to allocate scarce resources. But the guidance doesn't factor in health care inequalities. More
Rates of death in the groups treated with the drugs were worse than for those who received no treatment, and rates of patients on ventilators were similar, the study found. More
In the first edition of "Lown Hospitals Q&A," a recurring video series, Vikas Saini and Shannon Brownlee answer questions about hospital bailouts. More
The Minnesota legislature's fight over a new insulin access program encapsulates the difficulty and the controversy of even modest drug pricing reforms. More
While cutting benefits for emergency room doctors and other medical workers, TeamHealth and Envision have spent millions on ads meant to pressure politicians working on legislation to cap out-of-network costs for Americans. More
In early April, the U.S. surgeon general called COVID-19 "our Pearl Harbor moment, our 9/11 moment." But data from New York City suggested another analogy: It had become our Katrina moment. More
The fear of what's ahead is based on precedent. During the swine flu epidemic of 2009, Native Americans died at four to five times the rate of other Americans. More
This cluster randomized clinical trial tests the effects of receipt of a paper-based mammography screening decision aid for women 75 years and older on their screening decisions. More
A potential silver lining of the COVID-19 pandemic? An opportunity to permanently stop doing unnecessary elective procedures. More
Some doctors who have switched to telehealth during the pandemic are finding that it can offer personal and lighthearted connections with their patients. More
Whistleblowers at psychiatric facilities paint a picture of mismanaged responses and lax safety protocols—even alleging coverups of deaths. More
Data shows people with certain chronic conditions are more likely to get severe COVID-19 symptoms. Why are they hit harder and what explains the disease's disproportionate affect on African Americans? More
Reports of success in a Chicago trial suggest the drug has promise, not that it works. More
Gilead Sciences Inc’s shares surged 16% in after hours trading on Thursday following a media report detailing encouraging partial data from trials of the U.S. company’s experimental drug remdesivir in severe COVID-19 patients. More
There is no excerpt because this is a protected post. More
Health care workers are sharing real — and really painful — stories on social media. Doing that isn't always easy, but it is important. More
This Viewpoint stresses the importance of recognizing and directly addressing the challenges created by COVID-19 era physical distancing in the care of older adults. More